Skip to main content
Faith Kung, MD, Pediatric Hematology & Oncology, San Diego, CA, Rady Children's Hospital - San Diego

FaithHildaKungMD

Pediatric Hematology & Oncology San Diego, CA

Professor of Pediatrics, UCSD

Dr. Kung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kung's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1960 - 1961
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Pediatrics, 1957 - 1960
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1957

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1969 - 2019
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Top Doctors:San Diego Area Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Publications & Presentations

PubMed

Grant Support

  • MGI-114 In Children With Solid TumorsNational Center For Research Resources2000–2002
  • Pediatric Oncology GroupNational Cancer Institute1985–2002
  • POG 9575 Topotecan For Refractory LeukemiaNational Center For Research Resources1999
  • POG 9572 Byrostatin In Children With Solid TumorsNational Center For Research Resources1998–1999
  • POG 9571 Irinotecan In Children With Solid TumorsNational Center For Research Resources1998–1999
  • POG 9426 Treatment Of Hodgkins Disease With Dbve And IrradiationNational Center For Research Resources1998–1999
  • Pog9470--Ci 980 In Children With Solid TumorsNational Center For Research Resources1997–1999
  • Pog9153--Rhabdomyosarcoma Study/Laboratory Evaluation Of TumorNational Cancer Institute1994–1995
  • Pog9140--Phase II Therapy For Recurrent Or Refractory NeuroblastomaNational Cancer Institute1994–1995
  • Pog9139--Phase I Study Of Cisplatin And Irradiation In Brain Stem GliomasNational Cancer Institute1994–1995
  • Pog9110--Rotational Drug Therapy After First Marrow Relapse Of Non-T, Non-B AllNational Cancer Institute1994–1995
  • Pog9107--Phase II Pilot Study Of Infant LeukemiaNational Cancer Institute1994–1995
  • Pog9079--Phase I Study Of L-Pam/Ctx With ABM Rescue For Brain Tumors In ChildrenNational Cancer Institute1994–1995
  • Pog9075--Phase I Study Of Acivicin In Children With Solid TumorsNational Cancer Institute1994–1995
  • Pog9074--Phase I Study Of Xomazyme-H65 In Children With T-Cell All/LymphomaNational Cancer Institute1994–1995
  • Pog9072--Phase I Chemotherapy For Recurrent/Resistant Malignant Solid TumorsNational Cancer Institute1994–1995
  • Pog9071--Phase I Trial Of Fazarabine In Children With Acute LeukemiaNational Cancer Institute1994–1995
  • Pog9061-Phase II Systemic Therapy And Irradiation For All &CNS LeukemiaNational Cancer Institute1994–1995
  • Pog9060--Intensive Qod Ifosfamide Treatment For CNS Tumors In ChildrenNational Cancer Institute1994–1995
  • Pog9049--Phase III Study Of High-Risk Malignant Germ Cell Tumors In ChildrenNational Cancer Institute1994–1995
  • Pog9048--Phase II Study Of Malignant Germ Cell Tumors In ChildrenNational Cancer Institute1994–1995
  • Pog9046--Molecular Genetic Analysis Of Wilm'S TumorsNational Cancer Institute1994–1995
  • Pog9031--Cisplatin/Vp-16 Therapy Of Medulloblastoma/Pre VS Post IrradiationNational Cancer Institute1994–1995
  • Pog9006--6-Mp/Methotrexate VS Alternating Chemotheray For All In ChildhoodNational Cancer Institute1994–1995
  • Pog9005--Dose Intensification Of Methotrexate &6-Mercaptourine In Childhood AllNational Cancer Institute1994–1995
  • Pog8973--Etoposide (Vp-16) And Carboplatin In Children With Acute LeukemiaNational Cancer Institute1994–1995
  • Pog8970--Phase I Trial Of Fazarabine In Children With Refractory Solid TumorsNational Cancer Institute1994–1995
  • Pog8945--Phase III Chemotherapy For Hepatoblastoma &Hepatocellular CarcinomaNational Cancer Institute1994–1995
  • Pog8936--Phase II Study Of Carboplatin Treatment For Optic Pathway TumorsNational Cancer Institute1994–1995
  • Pog8935--Phase II Study Of Surgery AND/OR Radiotherapy For Optic Pathway TumorsNational Cancer Institute1994–1995
  • Pog8930--A Comprehensive Genetic Analysis Of Brain TumorsNational Cancer Institute1994–1995
  • Pog8889--Intergroup Rhabdomyosarcoma Study For Clinical Group IV DiseaseNational Cancer Institute1994–1995
  • Pog8871--Phase I Study Of Rtnf In Children With Refractory Solid TumorsNational Cancer Institute1994–1995
  • Pog8870--Phase I Trial Of Ifosfamide/Vp16/Mesna In Children With Acute LeukemiaNational Cancer Institute1994–1995
  • Pog8866--Phase II Asparaginase Therapy For Acute Lymphoblastic LeukemiaNational Cancer Institute1994–1995
  • Pog8865--Phase II Recombinant Alpha Interferon In Relapsed T Cell DiseaseNational Cancer Institute1994–1995
  • Pog8863--Phase II Study Of High Dose Cytosine Arabinoside In Childhood TumorsNational Cancer Institute1994–1995
  • Pog8862--Combination Chemotherapy Of Acute T-Lymphoblastic LeukemiaNational Cancer Institute1994–1995
  • Pog8850--Phase III Treatment Of Ewing'S Sarcoma And Neuroectodermal Bone TumorsNational Cancer Institute1994–1995
  • Pog8844--Bone Marrow Transplant In Children With Stage D NeuroblastomaNational Cancer Institute1994–1995
  • Pog8832--Combination Chemotherapy Followed By Radiotherapy For Brain TumorsNational Cancer Institute1994–1995
  • Pog8828--Late Effects Of Hodgkin'S DiseaseNational Cancer Institute1994–1995
  • Pog8827--Phase II Treatment Of Children With Hodgkin'S Disease In RelapseNational Cancer Institute1994–1995
  • Pog8821--Phase III Chemother/Apyautologous BMT In Children With AMLNational Cancer Institute1994–1995
  • Pog8820--Phase II/III Study Of VP-16, Amsa/5-Azacytidine In Childhood ANLLNational Cancer Institute1994–1995
  • Pog8788--Intergroup Rhabdomyosarcoma Study/Pilot Study For Clinical Group IIINational Cancer Institute1994–1995
  • Pog8761--Phase II Homoharringtonine Therapy For Nonlymphoblastic LeukemiaNational Cancer Institute1994–1995
  • Pog8751--Phase II Methotrexate Chemotherapy For Rhabdomyosarcoma In ChildrenNational Cancer Institute1994–1995
  • Pog8741--Treatment Of Patients With Stage C And Stage D NeuroblastomaNational Cancer Institute1994–1995
  • Pog8739--Phase II Immunotherapy With Alpha-2 Interferon For Brain TumorsNational Cancer Institute1994–1995
  • Pog8731--Phase II Trial Of Methotrexate In Treatment Of Brain Tumors In ChildrenNational Cancer Institute1994–1995
  • Pog8725--Phase III Chemotherapy/Radiation Therapy In Pediatric HodgkinsNational Cancer Institute1994–1995
  • Pog8719--Phase III Chemotherapy For Non-Hodgkin'S Lymphoma In ChildrenNational Cancer Institute1994–1995
  • Pog8704--Phase III Chemotherapy Of Childhood T Cell All &Lymphoblastic LymphomaNational Cancer Institute1994–1995
  • Pog8671--Phase I Immunotherapy With Ril-2 In Children With Solid TumorsNational Cancer Institute1994–1995
  • Pog8653--Phase III Study Of Childhood Soft Tissue SarcomasNational Cancer Institute1994–1995
  • Pog8651--Phase III Study Of Childhood Nonmetastatic OsteosarcomaNational Cancer Institute1994–1995
  • Pog8650--National Wilm'S Tumor And Clear Cell Sarcoma StudyNational Cancer Institute1994–1995
  • Pog8633--Postoperative Chemotherapy And Delayed Irradiation For Brain TumorsNational Cancer Institute1994–1995
  • Pog8625--Phase III Combined Therapy In Childhood Hodgkin'S DiseaseNational Cancer Institute1994–1995
  • Pog8617--Therapy For B-Cell Acute Lymphoblastic Leukemia And LymphomaNational Cancer Institute1994–1995
  • Pog8616--Phase III Chemotherapy For Childhood Burkitt And Non-Burkitts LymphomaNational Cancer Institute1994–1995
  • Pog8615--Phase III Study Of Large Cell Lymphomas In Children And AdolescentsNational Cancer Institute1994–1995
  • Pog8494--Phase I Study Of Fludarabine Phosphate In Pediatric PatientsNational Cancer Institute1994–1995
  • Pog8451--Intergroup Rhabdomyosarcoma StudyNational Cancer Institute1994–1995
  • POG 9086--Phase I Pilot Study Of Therapy For T-Cell All Or NHLNational Cancer Institute1994–1995
  • Phase II Recombinant Alpha Interferon In Chronic Myelogenous LeukemiaNational Cancer Institute1994–1995

Hospital Affiliations